Ketogenic diet yields distinct health improvements over Mediterranean and plant-based plans in trial
A small clinical trial compared three popular weight-loss diets in 55 obese adults with prediabetes and fatty liver disease. Participants on the ketogenic diet experienced greater reductions in liver fat and improved prediabetes markers than those on Mediterranean or plant-focused diets, even with similar weight loss. The study suggests keto may offer distinct metabolic benefits beyond weight reduction.
The trial’s design deliberately matched weight loss across groups—roughly 10% of starting body weight—so metabolic differences could be attributed to diet composition rather than calorie deficit alone. Participants received weekly dietitian guidance and pre-cooked frozen meals to ensure adherence. While all diets improved insulin sensitivity and cholesterol profiles, only keto significantly lowered liver triglyceride production and boosted liver insulin sensitivity, alongside reducing liver fat. Notably, about half of keto participants showed marked improvement in prediabetes markers, a key outcome given the participants’ baseline conditions.
These findings build on keto’s established role in treating epilepsy and its emerging investigation for psychiatric disorders. The study’s small size (55 participants) and short duration limit generalizability, but the controlled feeding design strengthens internal validity. The liver-specific benefits suggest keto may act through mechanisms beyond simple weight loss, possibly via reduced carbohydrate-driven fat synthesis in the liver.
This trial could reshape how clinicians counsel patients with obesity, prediabetes, and fatty liver disease, offering keto as a targeted option rather than a generic weight-loss tool. If replicated, it may influence dietary guidelines and insurance coverage for medically supervised keto programs. However, long-term adherence and safety remain open questions, and patients should weigh keto’s restrictive nature against its metabolic advantages. The findings may also spur research into personalized diet prescriptions based on liver health markers.